These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35624923)

  • 1. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.
    Morowitz JM; Pogson KB; Roque DA; Church FC
    Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise for Older Adults Improves the Quality of Life in Parkinson's Disease and Potentially Enhances the Immune Response to COVID-19.
    Hall ME; Church FC
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32899958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis of the Mechanisms Underlying COVID-19 Modulation of Parkinson's Disease.
    Zhang J; Bishir M; Barbhuiya S; Chang SL
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives.
    Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Ahmed EA; Batiha GE
    J Neurosci Res; 2023 Jun; 101(6):952-975. PubMed ID: 36717481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does COVID-19 Trigger the Risk for the Development of Parkinson's Disease? Therapeutic Potential of Vitamin C.
    Sandeep ; Subba R; Mondal AC
    Mol Neurobiol; 2023 Nov; ():. PubMed ID: 37957424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
    Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and neurodegenerative diseases.
    Fu YW; Xu HS; Liu SJ
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson's Disease.
    Angelopoulou E; Karlafti E; Georgakopoulou VE; Papalexis P; Papageorgiou SG; Tegos T; Savopoulos C
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease.
    Zhang J
    Front Neurol; 2022; 13():968193. PubMed ID: 36570463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia?
    Sivagurunathan N; Calivarathan L
    CNS Neurol Disord Drug Targets; 2024; 23(4):431-448. PubMed ID: 37073650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
    Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
    Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
    J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2, COVID-19 and Parkinson's Disease-Many Issues Need to Be Clarified-A Critical Review.
    Goerttler T; Kwon EH; Fleischer M; Stettner M; Tönges L; Klebe S
    Brain Sci; 2022 Mar; 12(4):. PubMed ID: 35447986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy.
    Sinha S; Mittal S; Roy R
    J Mov Disord; 2021 Sep; 14(3):184-192. PubMed ID: 34315206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders.
    Follmer C
    ACS Chem Neurosci; 2020 Dec; 11(24):4012-4016. PubMed ID: 33244974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Hospitalized Parkinson's Disease Patients with and without COVID-19.
    Parihar R; Ferastraoaru V; Galanopoulou AS; Geyer HL; Kaufman DM
    Mov Disord Clin Pract; 2021 Aug; 8(6):859-867. PubMed ID: 34226870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.
    Calderón-Garcidueñas L; Torres-Jardón R; Franco-Lira M; Kulesza R; González-Maciel A; Reynoso-Robles R; Brito-Aguilar R; García-Arreola B; Revueltas-Ficachi P; Barrera-Velázquez JA; García-Alonso G; García-Rojas E; Mukherjee PS; Delgado-Chávez R
    J Alzheimers Dis; 2020; 78(2):479-503. PubMed ID: 32955466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment.
    Anghelescu A; Onose G; Popescu C; Băilă M; Stoica SI; Postoiu R; Brumă E; Petcu IR; Ciobanu V; Munteanu C
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now.
    Boura I; Qamar MA; Daddoveri F; Leta V; Poplawska-Domaszewicz K; Falup-Pecurariu C; Ray Chaudhuri K
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.